Arbutus Biopharma Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
5.40
|
|
Average Rating
|
4.20
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.13
|
-0.12
|
0.01
|
7.69%
|
|
2022-06-30
|
-0.13
|
-0.10
|
0.03
|
23.08%
|
|
2022-03-31
|
-0.16
|
-0.11
|
0.05
|
31.25%
|
|
2021-12-31
|
-0.19
|
-0.15
|
0.04
|
21.05%
|
|
2021-09-30
|
-0.24
|
-0.24
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.22
|
-0.23
|
-0.01
|
-4.55%
|
|
2021-03-31
|
-0.23
|
-0.21
|
0.02
|
8.70%
|
|
2020-12-31
|
-0.22
|
-0.23
|
-0.01
|
-4.55%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.33
|
|
2021-12-31
|
-0.83
|
|
2020-12-31
|
-1.00
|
|
2019-12-31
|
-2.89
|
|
2018-12-31
|
-1.21
|
|
2017-12-31
|
-1.78
|
|
2016-12-31
|
-4.63
|
|
2015-12-31
|
-0.85
|
|
2014-12-31
|
-1.85
|
|
2013-12-31
|
-0.91
|
|
2012-12-31
|
2.06
|
|
2011-12-31
|
-0.90
|
|
2010-12-31
|
-1.69
|
|
2009-12-31
|
-0.65
|
|
2008-12-31
|
-0.35
|
|
2007-12-31
|
-0.65
|